Grant, Loan or Investor Partnership: Choosing the Right Innovate UK Route

Innovate UK doesn't just fund R&D one way. It runs three distinct instruments for the same broad purpose, non-repayable grants, repayable Innovation Loans, and Investor Partnerships that pair a smaller grant with private investment, and most companies default to "grant" simply because it's the most visible route. That's not always the right call. Which instrument suits you depends less on how innovative your project is and more on its stage, your appetite for debt or dilution, and whether you already have an investor relationship in place.

Three routes, one funder

All three sit under Innovate UK, but they solve different problems. A grant funds a defined piece of R&D you couldn't otherwise afford to do, with no repayment and no equity given up, in exchange for going through a competitive, scored application. A loan funds late-stage, close-to-market development at a much larger ticket size, repayable with interest once your product is generating revenue. An Investor Partnership funds a smaller share of a project's cost as a grant, but only alongside a private investor who is putting in real money at the same time, and only if that investor introduces you.

Picking the wrong one wastes months. A pre-revenue team without investor traction applying to Investor Partnerships will never get past the first stage, since an approved investor partner has to submit the expression of interest, not the applicant. A team at proof-of-concept stage applying for an Innovation Loan will be turned down because loans are explicitly for late-stage, close-to-market work. Knowing which door to walk through first is most of the battle.

Grants: what they suit and what they don't

A standard Innovate UK grant is the right instrument when your project is still at feasibility study, industrial research, or early experimental development stage, when you don't want to take on debt or give up equity, and when you don't yet have an investor relationship to lean on. It's also, by a wide margin, the most competitive route: you're scored against every other applicant in the competition, not just checked against an eligibility bar.

Funding rates follow a UK subsidy control scale that applies economy-wide, not just to one scheme: up to 70% of costs for micro and small businesses on feasibility studies and industrial research, falling to up to 45% for experimental development (35% for medium-sized businesses), according to UKRI's Investor Partnerships programme page, updated 7 May 2026, which sets out the same baseline rates that apply to standalone grant competitions. The remainder has to come from your own resources, which is exactly where grants start to strain: they don't cover working capital, and they don't stretch to production tooling or scale-up costs at volume. That's the gap the other two routes are built for.

Innovation Loans: what they suit and what they don't

Innovation Loans exist for one specific situation: a UK SME with a late-stage, close-to-market project that has real commercial potential but can't yet raise the money commercially or fund it from its own resources. Innovate UK's Innovation Loans guidance, updated 22 June 2026, describes the eligible activity as late-stage R&D and pre-commercial work, not early feasibility or proof-of-concept, and open rounds on the Innovation Funding Service put loan sizes at £100,000 to £5 million, covering up to 100% of eligible project costs. Interest is charged at 3.7% a year on amounts drawn during the project itself, with a further 3.7% deferred, then the full 7.4% applies during repayment alongside the deferred amount, per Innovate UK Business Connect's programme summary. Because those figures move between rounds, check the live competition brief on the Innovation Funding Service before you budget against them.

The trade-off is straightforward: no dilution, but a real repayment obligation once your project period ends, whether or not commercialisation goes to plan on schedule. That makes loans a poor fit for anything still carrying significant technical risk. They suit a team confident enough in the remaining R&D that they're willing to owe money against it, typically because the product is close enough to market that revenue is a realistic prospect within the repayment window. Our Innovation Loans competition guide covers the current round's specific terms and application process in more detail.

Investor Partnerships: what they suit and what they don't

Investor Partnerships only work if you already have, or can quickly build, a relationship with one of Innovate UK's approved investor partners. You cannot apply directly: an investor partner submits the expression of interest on your behalf, which means the real gatekeeping happens in the investor conversation, not the grant form. Once that's in place, Innovate UK's grant covers the same subsidy-control bands as a standard grant, but the investor's aligned commitment has to be at least equal to the grant for feasibility and industrial research projects, or at least double the grant for experimental development, confirmed by UKRI's programme page as of 7 May 2026. Since spring 2025 the programme has focused on UK Industrial Strategy sectors, which happen to line up closely with the sectors Innovate UK backs most heavily overall: advanced manufacturing, clean energy, creative industries, defence and security, digital and technologies, and life sciences.

Rounds run periodically rather than continuously, most recently as Growth Catalyst, and the last round closed on 3 February 2026 with the next date unconfirmed at the time of writing, so check the Innovation Funding Service for whether a round is currently open before building a case around this route. Our Investor Partnerships competition guide has the current round's detail, and our guide to winning an Investor Partnerships bid covers what a strong application looks like once an investor is on board. The honest read: if you don't already have investor interest, this isn't a route to chase for its own sake, it's a route to use once the investment conversation is already moving.

A decision framework by project stage and dilution appetite

The three routes map fairly cleanly onto where a project actually sits:

Two failure modes are worth naming directly. First, applying for a grant when your project is genuinely late-stage and close-to-market: you'll likely be told the work is too far along for the competition's scope, and a loan would have covered more of it anyway. Second, chasing an Investor Partnership before you have investor traction: the application can't even start without an investor partner attached, so time spent on it before that relationship exists is time spent on the wrong thing. If your project doesn't fit any of the three cleanly, for example if it's too early for a loan and you have no investor relationship, a standard grant competition, or a smaller pre-grant scheme, is usually the more honest starting point than forcing a fit.

How GrantHero helps you pick and prepare the right route

Working out which of these three actually fits your project, and whether the current round timing works for you, is exactly the kind of judgement call that's easy to get wrong from reading scheme pages in isolation. GrantHero's matching surfaces the live competitions across all three routes that your company is actually eligible for, rather than leaving you to cross-reference three separate parts of the Innovation Funding Service by hand, and flags when a route genuinely isn't right for where your project is, rather than encouraging you to apply anyway.

Once you know which route fits, drafting the application itself is where the platform combines with human expertise: AI drafts a first pass against the scored questions, and an experienced grant reviewer checks it before you submit. Our pricing page sets out what's included at each tier, from a free eligibility check through to a fully reviewed submission with expert sign-off.